Logo image of OOMA

OOMA INC (OOMA) Stock Fundamental Analysis

NYSE:OOMA - New York Stock Exchange, Inc. - US6834161019 - Common Stock - Currency: USD

12.34  +0.1 (+0.82%)

After market: 12.34 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to OOMA. OOMA was compared to 283 industry peers in the Software industry. OOMA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OOMA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

OOMA had positive earnings in the past year.
OOMA had a positive operating cash flow in the past year.
In the past 5 years OOMA always reported negative net income.
OOMA had a positive operating cash flow in each of the past 5 years.
OOMA Yearly Net Income VS EBIT VS OCF VS FCFOOMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

OOMA has a Return On Assets (-4.63%) which is in line with its industry peers.
OOMA's Return On Equity of -8.09% is in line compared to the rest of the industry. OOMA outperforms 51.24% of its industry peers.
Industry RankSector Rank
ROA -4.63%
ROE -8.09%
ROIC N/A
ROA(3y)-2.66%
ROA(5y)-2.46%
ROE(3y)-5.01%
ROE(5y)-4.92%
ROIC(3y)N/A
ROIC(5y)N/A
OOMA Yearly ROA, ROE, ROICOOMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

1.3 Margins

OOMA has a Gross Margin of 60.74%. This is comparable to the rest of the industry: OOMA outperforms 42.05% of its industry peers.
OOMA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for OOMA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y0.08%
OOMA Yearly Profit, Operating, Gross MarginsOOMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

5

2. Health

2.1 Basic Checks

OOMA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OOMA has more shares outstanding
Compared to 5 years ago, OOMA has more shares outstanding
OOMA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OOMA Yearly Shares OutstandingOOMA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
OOMA Yearly Total Debt VS Total AssetsOOMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

OOMA has an Altman-Z score of 3.49. This indicates that OOMA is financially healthy and has little risk of bankruptcy at the moment.
OOMA's Altman-Z score of 3.49 is fine compared to the rest of the industry. OOMA outperforms 63.25% of its industry peers.
OOMA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.49
ROIC/WACCN/A
WACC10.86%
OOMA Yearly LT Debt VS Equity VS FCFOOMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

OOMA has a Current Ratio of 1.09. This is a normal value and indicates that OOMA is financially healthy and should not expect problems in meeting its short term obligations.
OOMA has a worse Current ratio (1.09) than 72.08% of its industry peers.
OOMA has a Quick Ratio of 1.09. This is a bad value and indicates that OOMA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.83, OOMA is not doing good in the industry: 81.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.83
OOMA Yearly Current Assets VS Current LiabilitesOOMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

6

3. Growth

3.1 Past

OOMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.52%, which is quite good.
OOMA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.25% yearly.
OOMA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.50%.
OOMA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.12% yearly.
EPS 1Y (TTM)15.52%
EPS 3Y10.25%
EPS 5YN/A
EPS Q2Q%61.54%
Revenue 1Y (TTM)8.5%
Revenue growth 3Y10.13%
Revenue growth 5Y11.12%
Sales Q2Q%5.55%

3.2 Future

Based on estimates for the next years, OOMA will show a very strong growth in Earnings Per Share. The EPS will grow by 26.64% on average per year.
The Revenue is expected to grow by 7.06% on average over the next years.
EPS Next Y15.27%
EPS Next 2Y16.07%
EPS Next 3Y22.75%
EPS Next 5Y26.64%
Revenue Next Year4.37%
Revenue Next 2Y5.2%
Revenue Next 3Y5.91%
Revenue Next 5Y7.06%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OOMA Yearly Revenue VS EstimatesOOMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
OOMA Yearly EPS VS EstimatesOOMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.42, OOMA is valued on the expensive side.
75.62% of the companies in the same industry are more expensive than OOMA, based on the Price/Earnings ratio.
OOMA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.29.
With a Price/Forward Earnings ratio of 15.98, OOMA is valued correctly.
OOMA's Price/Forward Earnings ratio is rather cheap when compared to the industry. OOMA is cheaper than 82.69% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.08, OOMA is valued a bit cheaper.
Industry RankSector Rank
PE 18.42
Fwd PE 15.98
OOMA Price Earnings VS Forward Price EarningsOOMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

OOMA's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, OOMA is valued cheaper than 83.39% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.89
EV/EBITDA 103.4
OOMA Per share dataOOMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

OOMA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
OOMA's earnings are expected to grow with 22.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.21
PEG (5Y)N/A
EPS Next 2Y16.07%
EPS Next 3Y22.75%

0

5. Dividend

5.1 Amount

OOMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OOMA INC

NYSE:OOMA (4/17/2025, 8:04:00 PM)

After market: 12.34 0 (0%)

12.34

+0.1 (+0.82%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-04 2025-03-04/amc
Earnings (Next)05-26 2025-05-26/amc
Inst Owners73.77%
Inst Owner Change0%
Ins Owners7.91%
Ins Owner Change15.19%
Market Cap340.58M
Analysts81.54
Price Target18.67 (51.3%)
Short Float %1.95%
Short Ratio4.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.51%
Min EPS beat(2)7.43%
Max EPS beat(2)29.6%
EPS beat(4)4
Avg EPS beat(4)16.42%
Min EPS beat(4)7.43%
Max EPS beat(4)29.6%
EPS beat(8)6
Avg EPS beat(8)10.49%
EPS beat(12)10
Avg EPS beat(12)12.69%
EPS beat(16)14
Avg EPS beat(16)18.87%
Revenue beat(2)0
Avg Revenue beat(2)-1.05%
Min Revenue beat(2)-1.36%
Max Revenue beat(2)-0.73%
Revenue beat(4)1
Avg Revenue beat(4)-0.69%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)0.24%
Revenue beat(8)1
Avg Revenue beat(8)-1.31%
Revenue beat(12)2
Avg Revenue beat(12)-1.19%
Revenue beat(16)4
Avg Revenue beat(16)-0.9%
PT rev (1m)2.23%
PT rev (3m)2.23%
EPS NQ rev (1m)0.79%
EPS NQ rev (3m)25.12%
EPS NY rev (1m)8.87%
EPS NY rev (3m)8.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.26%
Revenue NY rev (1m)-1.56%
Revenue NY rev (3m)-1.62%
Valuation
Industry RankSector Rank
PE 18.42
Fwd PE 15.98
P/S 1.33
P/FCF 16.89
P/OCF 12.8
P/B 3.99
P/tB 8.51
EV/EBITDA 103.4
EPS(TTM)0.67
EY5.43%
EPS(NY)0.77
Fwd EY6.26%
FCF(TTM)0.73
FCFY5.92%
OCF(TTM)0.96
OCFY7.81%
SpS9.31
BVpS3.09
TBVpS1.45
PEG (NY)1.21
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.63%
ROE -8.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.74%
FCFM 7.85%
ROA(3y)-2.66%
ROA(5y)-2.46%
ROE(3y)-5.01%
ROE(5y)-4.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y0.08%
F-Score5
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 64.08%
Cap/Sales 2.51%
Interest Coverage N/A
Cash Conversion 852.48%
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.83
Altman-Z 3.49
F-Score5
WACC10.86%
ROIC/WACCN/A
Cap/Depr(3y)75.59%
Cap/Depr(5y)79.48%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.52%
EPS 3Y10.25%
EPS 5YN/A
EPS Q2Q%61.54%
EPS Next Y15.27%
EPS Next 2Y16.07%
EPS Next 3Y22.75%
EPS Next 5Y26.64%
Revenue 1Y (TTM)8.5%
Revenue growth 3Y10.13%
Revenue growth 5Y11.12%
Sales Q2Q%5.55%
Revenue Next Year4.37%
Revenue Next 2Y5.2%
Revenue Next 3Y5.91%
Revenue Next 5Y7.06%
EBIT growth 1Y-73.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.96%
EBIT Next 3Y31.67%
EBIT Next 5Y29.97%
FCF growth 1Y229.72%
FCF growth 3Y101.61%
FCF growth 5YN/A
OCF growth 1Y116.79%
OCF growth 3Y58.67%
OCF growth 5YN/A